Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
There were no contracts, instructions or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), nor were there any non-Rule 10b5-1 trading arrangements, entered into or terminated by our directors and officers (as defined under Rule 16b-1(f) of the Exchange Act) during the quarter ended April 4, 2026. There were no non-Rule 10b5-1 trading arrangements entered into or terminated during the quarter ended April 4, 2026
41
Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of this report:
Exhibit
Number
3.1* Fifth Amended and Restated Certificate of Incorporation (filed as Exhibit 3.1 to the Form 10-Q filed on August 5, 2025).
3.2* Sixth Amended and Restated Bylaws of Silicon Laboratories Inc. (filed as Exhibit 3.1 to the Form 8-K filed on April 21, 2023).
4.1* Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement).
31.1 Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
32.1** Certification as required by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________
* Incorporated herein by reference to the indicated filing.
** F urnished herewith.
42
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SILICON LABORATORIES INC.
May 5, 2026 /s/ R. Matthew Johnson
Date R. Matthew Johnson
President and
Chief Executive Officer
(Principal Executive Officer)
May 5, 2026 /s/ Dean Butler
Date Dean Butler
Senior Vice President and
Chief Financial Officer
(Principal Financial Officer)
May 5, 2026 /s/ Mark D. Mauldin
Date Mark D. Mauldin
Chief Accounting Officer
(Principal Accounting Officer)
43
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.